Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial

Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial

Item
http://www.wikidata.org/entity/Q28193401
Administration of low molecular weight and unfractionated heparin during percutaneous coronary interventionEfficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisLow-molecular-weight heparins as adjunctive therapy to thrombolytics: extracting the best data.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.Warfarin and fibrinolysis--a challenging combination: an observational cohort study.Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.Early management of ST elevation myocardial infarction: a review of practice.Pharmacological antithrombotic adjuncts to percutaneous coronary intervention.Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarctionAcute coronary syndromes: Diagnosis and management, part II.InforMatrix: ADP antagonists in acute coronary syndromes.Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.Creating synergy in our health system: The challenges of primary angioplastyPharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor.Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis.ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
P2860

Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial

Item
http://www.wikidata.org/entity/Q28193401
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@ast
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@en
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@nl
type
label
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@ast
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@en
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@nl
prefLabel
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@ast
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@en
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Angiographic and clinical outc ...... s in the CLARITY-TIMI 28 Trial
@en
P2093
P304
P31
P356
10.1161/CIRCULATIONAHA.105.595397
P407
P433
P478
P50
P577
P698
P921